Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts

Pathology

Volumn 35, Issue 5, 2003, Pages 422-427

  Leong, Chooi Fun ^a   Raudhawati, Osman ^a   Cheong, Soon Keng ^a   Sivagengei, Kulaveerasingam ^a   Hamidah, Hussin Noor ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Acute myeloid leukaemia; Acute myeloid leukemia; EMA; Monoblasts; Monocytes

Indexed keywords

CD14 ANTIGEN; CHLORDANE; EPITHELIAL MEMBRANE ANTIGEN; GLYCOPROTEIN P 15095; MONOCLONAL ANTIBODY; MUCIN 1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CELL LINEAGE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; PREVALENCE; PROTEIN EXPRESSION; SAMPLE;

EID: 0142209273     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020310001602576     Document Type: Article

References (29)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of acute leukaemias French-American-British (FAB) cooperative group. Br J Haematol 1976; 33: 451-8.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 10: 620-5.
3. del Canizo MC, San Miguel JF, Gonzalez M, Anta JP, Orfao A, Lopez-Borrasca A. Discrepancies between morphologic, cytochemical and immunologic characteristics in acute myeloblastic leukemia. Am J Clin Pathol 1987; 88: 38-42.
4. Neame PB, Soamboonsrup P, Browman GP, et al. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood 1986; 68: 1355-62.
5. Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. B J Haematol 1988; 68: 487-94.
6. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunologic Characterization of Leukemias (EGIL). Leukaemia 1995; 9: 1783-6.
7. Browman GP, Neame PB, Soamboonsrup P. The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukaemia. Blood 1986; 68: 900-5.
8. Paietta E, Andersen J, Wiernik PH. A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukaemia. Eastern Cooperative Oncology Group. Leukemia 1996; 10: 1-4.
9. Pessano S, Palumbo A, Ferrero D, et al. Subpopulation of heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies. Blood 1984; 64: 275-81.
10. Drexler HG, Minowada J. The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias. Leuk Res 1986; 10: 279-90.
11. Foon KA, Todd RF 3rd. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
12. Cheong SK, Chin SF, Azizon O, Hamidah NH. Unexpected EMA and cytokeratin expression in a case of infantile acute monoblastic leukaemia. Hematology 1996; 1: 223-5.
13. Cheong SK, Leong CF, Sivagengei K, Hamidah NH, Ainoon O. Epithelial membrane antigen (EMA) expression in hematological malignancies. Blood 1998; 92: 199b.
14. Cordell J, Richardson TC, Pulford KA, et al. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985; 52: 347-54.
15. Thomas P, Battifora H. Keratin versus epithelial membrane antigen in tumour diagnosis: an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 1987; 18: 728-34.
16. Pinkus GS, Kurtin PJ. Epithelial membrane antigen. A diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 1985; 16: 929-40.
17. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Am J Pathol 1988; 130: 59-70.
18. Strickler JG, Weiss LM, Copenhaver CM, et al. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma with emphasis on T-cell lymphomas. Hum Pathol 1987; 18: 808-14.
19. Bucsky P, Favara B, Feller AC, et al. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: guidelines for differential diagnosis - report of the Histiocyte Society. Med Ped Oncol 1994; 22: 200-3.
20. Jarvinen M, Anderson LC, Virtanen I. K562 erythroleukemia cells express cytokeratins 8, 18, 19 and epithelial membrane antigen that disappear after induced differentiation. J Cell Physiol 1990; 143: 310-20.
21. Ghosh AK, Gatter KC, Dunnill MS, Mason DY. Immunohistological staining of reactive mesothelium, mesothelioma and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol 1987; 40: 19-25.
22. Wykes M, MacDonald KPA, Tran M, et al. MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. J Leukocyte Biol 2002; 72: 692-701.
23. Brossart B, Schneider A, Dill P, et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res 2001; 64: 6846-50.
24. Hanisch F-G. Specificity clusters of MUC1-reactive mouse monoclonal antibodies. Tumor Biol 1998; 19 (Suppl 1): 111-7.
25. Cao Y, Karsten U, Hilgers J. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues. Tumor Biol 1998; 19 (Suppl 1): 88-99.
26. ten Berge RL, Snijdewint FGM, von Mensdorff-Pouilly S, et al. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. J Clin Pathol 2001; 54: 933-9.
27. Scott CS, Morgan M, Limbert HJ, MacKarill ID, Roberts BE. Cytochemical, immunological and ANAE isoenzyme studies in acute myelomonocytic leukaemia; a study of 39 cases. Scand J Haematol 1985; 35: 284-91.
28. Drexler HG, Scott CS. Morphological and immunological aspects of leukemia diagnosis. In: Scott CS, editor. Leukemia Cytochemistry and Diagnosis. 1st edn. Chichester: Ellis Horwood, 1989.
29. Master PS, Richards SJ, Kendall J, Roberts BE, Scott CS. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia. Blut 1989; 59: 221-5.